English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Israel's HBL Receives $2 Million from Chinese Investors

Jun. 28, 2015

June 28, 2015: Hadasit Bio Holdings, a holding company for medical technology developed at Hadassah Medical Center in Jerusalem, announced a $2 million investment from unspecified Chinese investors. The investors will receive 25% of the company's shares and preferential treatment on China rights to any of HBL’s products.